Home/Filings/4/0001493152-24-004813
4//SEC Filing

Grossman Fred 4

Accession 0001493152-24-004813

CIK 0001835022other

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 8:00 PM ET

Size

7.7 KB

Accession

0001493152-24-004813

Insider Transaction Report

Form 4
Period: 2024-01-31
Grossman Fred
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-01-31+81,81981,819 total
    Exercise: $5.90Exp: 2034-01-31Common Stock, par value $0.0001 per share (81,819 underlying)
  • Award

    Stock Option (right to buy)

    2024-01-31+74,06974,069 total
    Exercise: $5.90Exp: 2034-01-31Common Stock, par value $0.0001 per share (74,069 underlying)
Footnotes (2)
  • [F1]The option will vest in 36 equal monthly installments commencing February 29, 2024, subject to continuous service on each vesting date.
  • [F2]The option will vest as to 24,689 shares on July 11, 2024, with the remaining shares vesting in 24 equal monthly installments.

Documents

1 file

Issuer

Coya Therapeutics, Inc.

CIK 0001835022

Entity typeother

Related Parties

1
  • filerCIK 0001985154

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:00 PM ET
Size
7.7 KB